Publications in collaboration with researchers from Universidad Autónoma de Madrid (14)

2025

  1. Contilistat, a New Multitarget Small Polyfunctionalized Indole Derivative

    Synlett, Vol. 36, Núm. 16, pp. 2655-2660

2024

  1. Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases

    Journal of Medicinal Chemistry, Vol. 67, Núm. 18, pp. 16533-16555

  2. Ni(2,2′:6′,2′′-terpyridine)2: a high-spin octahedral formal Ni(0) complex

    Dalton Transactions, Vol. 53, Núm. 20, pp. 8550-8554

  3. Nickel-catalyzed cycloisomerization of 1,5-allenynes

    Advanced Synthesis and Catalysis, Vol. 366, Núm. 4, pp. 790-797

  4. Synthesis of ladderanes by nickel-catalyzed cyclodimerization of allenynes: scope and mechanism

    Advanced Synthesis and Catalysis, Vol. 366, Núm. 22, pp. 4755-4764

2023

  1. Metal-catalyzed borylative cyclization reactions of polyunsaturated substrates for the synthesis of heterocycles

    Targets in Heterocyclic Systems, Vol. 27, pp. 309-340

2022

  1. Nickel-catalyzed hydroborylative polycyclization of allenynes: an atom-economical and diastereoselective synthesis of bicyclic 5-5 fused rings

    Advanced Synthesis and Catalysis, Vol. 364, Núm. 10, pp. 1716-1723

  2. Polyfunctionalized α-Phenyl-tert-butyl(benzyl)nitrones: Multifunctional Antioxidants for Stroke Treatment

    Antioxidants, Vol. 11, Núm. 9

2021

  1. On the mechanism of the formation of alkyl-Ni(i) catalysts

    Chemical Communications, Vol. 57, Núm. 19, pp. 2424-2427

  2. Pd-catalyzed C(sp3)-C(sp) bond formation in iodocyclobutenes

    Chemical Communications, Vol. 57, Núm. 68, pp. 8456-8459

2020

  1. In Vitro and in Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases

    ACS Chemical Neuroscience, Vol. 11, Núm. 22, pp. 3793-3801

2019

  1. Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 34, Núm. 1, pp. 479-489

  2. New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition

    Journal of Medicinal Chemistry, Vol. 62, Núm. 24, pp. 11416-11422

  3. Quinoxalinetacrine QT78, a cholinesterase inhibitor as a potential ligand for Alzheimer’s disease therapy

    Molecules, Vol. 24, Núm. 8